This Phase I/II trial evaluated an investigational maternal hexavalent polysaccharide−protein conjugate GBS vaccine in non-pregnant females and pregnant participants and their infants. [Nature Medicine] Full Article
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.